SCHWARTZ BRIAN 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
SCHWARTZ BRIAN
Director
Transactions
- Award
Common Stock
2021-06-15+1,187→ 3,561 total - Award
Stock Option (right to buy)
2021-06-15+4,748→ 7,122 totalExercise: $6.69From: 2022-06-15Exp: 2031-06-15→ Common Stock (4,748 underlying) - Award
Stock Option (right to buy)
2021-06-15+2,374→ 7,122 totalExercise: $6.69From: 2024-06-15Exp: 2031-06-15→ Common Stock (2,374 underlying) - Award
Common Stock
2021-06-15+2,374→ 3,561 total
Footnotes (3)
- [F1]The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022.
- [F2]The reporting person received an award of 1,187 restricted stock units on June 15, 2021, which shall vest in three equal installments on June 15, 2022, June 15, 2023, and June 15, 2024.
- [F3]These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.